• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性巨结肠症慢性便秘的阿育吠陀疗法——病例研究

Ayurvedic management of chronic constipation in Hirschsprung disease - A case study.

作者信息

Singh Sarvesh Kumar, Rajoria Kshipra

机构信息

Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India.

Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India.

出版信息

J Ayurveda Integr Med. 2018 Apr-Jun;9(2):131-135. doi: 10.1016/j.jaim.2017.11.004. Epub 2018 May 29.

DOI:10.1016/j.jaim.2017.11.004
PMID:29853328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6033722/
Abstract

Hirschsprung disease (HSCR) or congenital intestinal aganglionosis is characterized by complete absence of neuronal ganglion cells from a portion of the intestinal tract, most commonly in the large intestine. The main sign or symptom of HSCR is constipation usually appearing shortly after birth. This constipation is chronic in nature and usually not relieved with laxatives. The present case is of a patient having HSCR which was successfully managed with Ayurvedic treatment. A four year old boy with complaint of severe constipation, abdominal pain, abdominal distension and occasional vomiting was treated with Panchakarma procedures and Ayurvedic oral drugs. The Ayurvedic diagnosis of the case was Pakvasayagata vata. Shashtikashali pinda swedana (sudation with medicated cooked bolus of rice) and Matra basti (enema with medicated oil) with Ashwagandha taila (Ayurvedic medicated oil) was given for first 16 days. From the 2nd month of treatment, Matra basti was administered daily for 3 months in the dose of 25 ml. In 5th and 6th month Matra basti was administered on alternate days in the dose of 25 ml. From the 7th month Matra basti was administered once weekly in the dose of 25 ml. In 14th month Shashtikashali pinda swedana and Erandmooladi yapna basti (medicated enema) was given for 16 days. Eight scales based Medical outcome study (MOS) - 36 item short form - health surveys was periodically assessed for outcome which shows good improvement. Experience of this case showed that HSCR may satisfactory be managed with Ayurvedic treatment.

摘要

先天性巨结肠症(HSCR)或先天性肠道神经节缺失症的特征是肠道的一部分完全没有神经节细胞,最常见于大肠。HSCR的主要体征或症状是便秘,通常在出生后不久出现。这种便秘本质上是慢性的,通常用泻药无法缓解。本病例是一名患有HSCR的患者,通过阿育吠陀疗法成功治愈。一名4岁男孩,主诉严重便秘、腹痛、腹胀和偶尔呕吐,接受了五种疗法程序和阿育吠陀口服药物治疗。该病例的阿育吠陀诊断为“pakvasayagata vata”。最初16天给予“Shashtikashali pinda swedana”(用加药煮熟的饭团进行发汗)和用“Ashwagandha taila”(阿育吠陀药油)进行“Matra basti”(药油灌肠)。从治疗的第2个月开始,每天给予25毫升剂量的“Matra basti”,持续3个月。在第5个月和第6个月,每隔一天给予25毫升剂量的“Matra basti”。从第7个月开始,每周给予一次25毫升剂量的“Matra basti”。在第14个月,给予“Shashtikashali pinda swedana”和“Erandmooladi yapna basti”(药制灌肠剂)16天。定期使用基于八个量表的医学结局研究(MOS)-36项简表-健康调查来评估结果,结果显示有明显改善。该病例的经验表明,HSCR可以通过阿育吠陀疗法得到令人满意的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d93/6033722/ad77ec666604/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d93/6033722/50cbf875d185/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d93/6033722/ad77ec666604/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d93/6033722/50cbf875d185/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d93/6033722/ad77ec666604/gr2.jpg

相似文献

1
Ayurvedic management of chronic constipation in Hirschsprung disease - A case study.先天性巨结肠症慢性便秘的阿育吠陀疗法——病例研究
J Ayurveda Integr Med. 2018 Apr-Jun;9(2):131-135. doi: 10.1016/j.jaim.2017.11.004. Epub 2018 May 29.
2
Ayurvedic approach for management of ankylosing spondylitis: A case report.阿育吠陀疗法治疗强直性脊柱炎:一例报告。
J Ayurveda Integr Med. 2016 Mar;7(1):53-6. doi: 10.1016/j.jaim.2015.10.002. Epub 2016 May 24.
3
Ayurvedic management for a rare disorder Takayasu arteritis - A case report.罕见疾病高安动脉炎的阿育吠陀疗法——病例报告
Ayu. 2020 Apr-Jun;41(2):79-86. doi: 10.4103/ayu.AYU_61_19. Epub 2021 Oct 23.
4
Ayurvedic approach in the management of spinocerebellar ataxia-2.阿育吠陀疗法在脊髓小脑共济失调2型治疗中的应用
Anc Sci Life. 2016 Jan-Mar;35(3):167-72. doi: 10.4103/0257-7941.179873.
5
Ayurvedic approach in the management of spinal cord injury: A case study.阿育吠陀疗法在脊髓损伤管理中的应用:一项案例研究。
Anc Sci Life. 2015 Apr-Jun;34(4):230-4. doi: 10.4103/0257-7941.160870.
6
Management of post-hysterectomy urinary incontinence with composite Ayurveda treatment - A case report.阿育吠陀综合疗法治疗子宫切除术后尿失禁——病例报告
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100961. doi: 10.1016/j.jaim.2024.100961. Epub 2024 Sep 26.
7
Ayurvedic management in cervical spondylotic myelopathy.颈椎病性脊髓病的阿育吠陀疗法
J Ayurveda Integr Med. 2017 Jan-Mar;8(1):49-53. doi: 10.1016/j.jaim.2016.08.011. Epub 2017 Mar 9.
8
Ayurvedic management of spondyloepiphyseal dysplasia tarda, a rare hereditary disorder.迟发性脊椎骨骺发育不良的阿育吠陀疗法,一种罕见的遗传性疾病。
J Ayurveda Integr Med. 2016 Oct-Dec;7(4):249-254. doi: 10.1016/j.jaim.2016.10.002. Epub 2016 Nov 25.
9
A clinical evaluation of and in the management of with special reference to benign prostatic hyperplasia.对[具体药物名称1]和[具体药物名称2]在治疗[疾病名称]尤其是良性前列腺增生方面的临床评估,并特别提及[具体相关内容]。 (你提供的原文似乎不完整,部分内容缺失,我根据格式进行了补充性翻译)
Ayu. 2018 Apr-Jun;39(2):65-71. doi: 10.4103/ayu.AYU_117_15.
10
An ayurvedic approach in the management of Siragatavata complicated with Dusta Vrana.一种阿育吠陀疗法用于治疗合并有不洁创伤的西拉加塔瓦塔病。
J Ayurveda Integr Med. 2021 Jan-Mar;12(1):151-155. doi: 10.1016/j.jaim.2019.10.006. Epub 2020 Mar 9.

引用本文的文献

1
Jatharagni and Prakriti of young Indian adult population: A descriptive cross-sectional study.印度年轻成年人群的胃火与体质:一项描述性横断面研究。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100438. doi: 10.1016/j.jaim.2021.04.008. Epub 2022 Jan 29.

本文引用的文献

1
Ayurvedic management of spondyloepiphyseal dysplasia tarda, a rare hereditary disorder.迟发性脊椎骨骺发育不良的阿育吠陀疗法,一种罕见的遗传性疾病。
J Ayurveda Integr Med. 2016 Oct-Dec;7(4):249-254. doi: 10.1016/j.jaim.2016.10.002. Epub 2016 Nov 25.
2
Congenital aganglionic megacolon in Nigerian adults: two case reports and review of the literature.尼日利亚成年人先天性无神经节巨结肠:两例病例报告及文献综述
Niger J Clin Pract. 2011 Apr-Jun;14(2):249-52. doi: 10.4103/1119-3077.84032.
3
Hirschsprung's disease.先天性巨结肠症
Semin Pediatr Surg. 2010 Aug;19(3):194-200. doi: 10.1053/j.sempedsurg.2010.03.004.
4
Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests.先天性巨结肠症的诊断:常见检查的前瞻性比较准确性研究
J Pediatr. 2005 Jun;146(6):787-92. doi: 10.1016/j.jpeds.2005.01.044.
5
Hirschsprung disease, associated syndromes, and genetics: a review.先天性巨结肠症、相关综合征与遗传学:综述
J Med Genet. 2001 Nov;38(11):729-39. doi: 10.1136/jmg.38.11.729.
6
Genetics of Hirschsprung disease.先天性巨结肠症的遗传学
Curr Opin Pediatr. 2000 Dec;12(6):610-7. doi: 10.1097/00008480-200012000-00017.
7
The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?SF36健康调查问卷:一种适合在英国国家医疗服务体系(NHS)中常规使用的结果测量工具?
BMJ. 1993 May 29;306(6890):1440-4. doi: 10.1136/bmj.306.6890.1440.
8
Diagnosis and treatment of Hirschsprung's disease in Japan. An analysis of 1628 patients.日本先天性巨结肠症的诊断与治疗。对1628例患者的分析。
Ann Surg. 1984 Apr;199(4):400-5. doi: 10.1097/00000658-198404000-00005.